Market Value333,536,277
Total Holdings72
File Date2023-05-15
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
SAGE / Sage Therapeutics, Inc.
ARAY / Accuray Incorporated
CYTK / Cytokinetics, Incorporated
BHVN / Biohaven Ltd.
AXGN / Axogen, Inc.
ITOS / iTeos Therapeutics, Inc.
ORIC / ORIC Pharmaceuticals, Inc.
STXS / Stereotaxis, Inc.
SYRS / Syros Pharmaceuticals, Inc.
LCTX / Lineage Cell Therapeutics, Inc.
LRMR / Larimar Therapeutics, Inc.
RCUS / Arcus Biosciences, Inc.
KROS / Keros Therapeutics, Inc.
ACRV / Acrivon Therapeutics, Inc.
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
MDNA / Medicenna Therapeutics Corp
IKNA / Ikena Oncology, Inc.
IDYA / IDEAYA Biosciences, Inc.
VIGL / Vigil Neuroscience, Inc.
APLS / Apellis Pharmaceuticals, Inc.
ACET / Adicet Bio, Inc.
PRQR / ProQR Therapeutics N.V.
MASI / Masimo Corporation
MRUS / Merus N.V.
NBIX / Neurocrine Biosciences, Inc.
KURA / Kura Oncology, Inc.
CSII / Cardiovascular Systems Inc.
PRDS / Pardes Biosciences Inc
AFMD / Affimed N.V.
BMEA / Biomea Fusion, Inc.
FSTX / F-star Therapeutics Inc
ETNB / 89bio, Inc.
CINC / CinCor Pharma Inc
DXCM / DexCom, Inc.
NXTC / NextCure, Inc.
SCYX / SCYNEXIS, Inc.
REUN / Reunion Neuroscience Inc
/ THESEUS PHARMACEUTICALS INC
NRIX / Nurix Therapeutics, Inc.
MREO / Mereo BioPharma Group plc - Depositary Receipt (Common Stock)
SPRB / Spruce Biosciences, Inc.
MORF / Morphic Holding, Inc.
FATE / Fate Therapeutics, Inc.
SPRO / Spero Therapeutics, Inc.
CBAY / CymaBay Therapeutics, Inc.
PHAS / PhaseBio Pharmaceuticals Inc
GNFT / Genfit S.A.
DICE / DICE Therapeutics Inc
KPTI / Karyopharm Therapeutics Inc.
BCRX / BioCryst Pharmaceuticals, Inc.
RGLS / Regulus Therapeutics Inc.
MGNX / MacroGenics, Inc.
ISEE / IVERIC bio Inc
BDTX / Black Diamond Therapeutics, Inc.
EWTX / Edgewise Therapeutics, Inc.
IBB / iShares Trust - iShares Biotechnology ETF
AUTL / Autolus Therapeutics plc - Depositary Receipt (Common Stock)
INGN / Inogen, Inc.
SNDX / Syndax Pharmaceuticals, Inc.
KALV / KalVista Pharmaceuticals, Inc.
STRO / Sutro Biopharma, Inc.
ATRC / AtriCure, Inc.
RVMD / Revolution Medicines, Inc.
CGEN / Compugen Ltd.
BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock)
ALEC / Alector, Inc.
SURF / Surface Oncology Inc
BWAY / BrainsWay Ltd. - Depositary Receipt (Common Stock)
MRTX / Mirati Therapeutics, Inc.
KRTX / Karuna Therapeutics, Inc.
MRSN / Mersana Therapeutics, Inc.
XBI / SPDR Series Trust - SPDR S&P Biotech ETF
STIM / Neuronetics, Inc.
ATXS / Astria Therapeutics, Inc.
CMPX / Compass Therapeutics, Inc.
GLPG / Galapagos NV - Depositary Receipt (Common Stock)
VKTX / Viking Therapeutics, Inc.
KNTE / Kinnate Biopharma Inc.
MDWD / MediWound Ltd.
ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock)
IPSC / Century Therapeutics, Inc.
BPMC / Blueprint Medicines Corporation
XENE / Xenon Pharmaceuticals Inc.